Literature DB >> 2887090

The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients.

O Lingjaerde, U G Ahlfors, P Bech, S J Dencker, K Elgen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2887090     DOI： 10.1111/j.1600-0447.1987.tb10566.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand Suppl        ISSN： 0065-1591


× No keyword cloud information.
  326 in total

1.  MRI signal hyperintensities and treatment remission of geriatric depression.

Authors:  Faith M Gunning-Dixon; Michael Walton; Janice Cheng; Jessica Acuna; Sibel Klimstra; Molly E Zimmerman; Adam M Brickman; Matthew J Hoptman; Robert C Young; George S Alexopoulos
Journal:  J Affect Disord       Date:  2010-05-07       Impact factor: 4.839

2.  The Norwegian naturalistic treatment study of depression in general practice (NORDEP)-I: randomised double blind study.

Authors:  U F Malt; O H Robak; H P Madsbu; O Bakke; M Loeb
Journal:  BMJ       Date:  1999-05-01

Review 3.  Quantifying adverse drug events : are systematic reviews the answer?

Authors:  Mahyar Etminan; Bruce Carleton; Paula A Rochon
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

4.  Comprehensive medication review: development of a collaborative procedure.

Authors:  Saija Leikola; Lea Tuomainen; Sirpa Peura; Antti Laurikainen; Alan Lyles; Eeva Savela; Marja Airaksinen
Journal:  Int J Clin Pharm       Date:  2012-06-19

5.  Comparative efficacy and durability of continuation phase cognitive therapy for preventing recurrent depression: design of a double-blinded, fluoxetine- and pill placebo-controlled, randomized trial with 2-year follow-up.

Authors:  Robin B Jarrett; Michael E Thase
Journal:  Contemp Clin Trials       Date:  2010-05-06       Impact factor: 2.226

6.  The RSM-scale: a pilot study on a new specific scale for self- and observer-rated quality of life in patients with schizophrenia.

Authors:  M Riedel; I Spellmann; R Schennach-Wolff; M Obermeier; R Musil
Journal:  Qual Life Res       Date:  2010-10-05       Impact factor: 4.147

7.  Lack of association between 71 variations located in candidate genes and response to acute haloperidol treatment.

Authors:  Ina Giegling; Antonio Drago; Martin Schäfer; Annette M Hartmann; Thomas Sander; Mohammad Reza Toliat; Hans-Jürgen Möller; Diana De Ronchi; Hans H Stassen; Dan Rujescu; Alessandro Serretti
Journal:  Psychopharmacology (Berl)       Date:  2010-11-16       Impact factor: 4.530

8.  Treatment of insomnia in depressed insomniacs: effects on health-related quality of life, objective and self-reported sleep, and depression.

Authors:  W Vaughn McCall; Jill N Blocker; Ralph D'Agostino; James Kimball; Niki Boggs; Barbara Lasater; Roger Haskett; Andrew Krystal; William M McDonald; Peter B Rosenquist
Journal:  J Clin Sleep Med       Date:  2010-08-15       Impact factor: 4.062

9.  Safety, tolerability and subject-rated effects of acute intranasal cocaine administration during atomoxetine maintenance.

Authors:  William W Stoops; John W Blackburn; David A Hudson; Lon R Hays; Craig R Rush
Journal:  Drug Alcohol Depend       Date:  2007-08-24       Impact factor: 4.492

10.  Feasibility, safety, and efficacy of the combination of D-serine and computerized cognitive retraining in schizophrenia: an international collaborative pilot study.

Authors:  Deepak C D'Souza; Rajiv Radhakrishnan; Edward Perry; Savita Bhakta; Nagendra M Singh; Richa Yadav; Danielle Abi-Saab; Brian Pittman; Santosh K Chaturvedi; Mahendra P Sharma; Morris Bell; Chittaranjan Andrade
Journal:  Neuropsychopharmacology       Date:  2012-10-24       Impact factor: 7.853
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.